Standout Papers

Bioanalytical Method Validation—A Revisit with a Decade of Progress 2000 2026 2008 2017 1.3k
  1. Bioanalytical Method Validation—A Revisit with a Decade of Progress (2000)
    Vinod P. Shah, Kamal K. Midha et al. Pharmaceutical Research

Citation Impact

Citing Papers

A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
2012
Pharmacokinetic-Pharmacodynamic Relationships for the Heat Shock Protein 90 Molecular Chaperone Inhibitor 17-Allylamino, 17-Demethoxygeldanamycin in Human Ovarian Cancer Xenograft Models
2005
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Parenteral Anticoagulants
2012 Standout
Mass spectrometry‐based metabolomics
2006 Standout
Catalytic asymmetric synthesis of new halogenated chiral synthons
1997 StandoutNobel
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum
2015 StandoutNobel
Simultaneous Quantification of Erlotinib, Gefitinib, and Imatinib in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry
2009
Measurement of Total Serum Testosterone in Adult Men: Comparison of Current Laboratory MethodsVersusLiquid Chromatography-Tandem Mass Spectrometry
2004
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
1999 Standout
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies
2008
Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics
2010 StandoutNobel
Position Stand on Androgen and Human Growth Hormone Use
2009
Pharmacokinetic aspects of biotechnology products
2004
HSP90 and the chaperoning of cancer
2005 Standout
Phenylisothiocyanate and dansyl chloride precolumn derivatizations for the high-performance liquid chromatography analysis of the antitumoral agent ES-285 in dog plasma
2003
Validation of new methods
2006 Standout
Quantitative high‐throughput analysis of drugs in biological matrices by mass spectrometry
2003
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
LC–ESI-MS/MS determination of 4-hydroxy-trans-2-nonenal Michael adducts with cysteine and histidine-containing peptides as early markers of oxidative stress in excitable tissues
2005
Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma
2007
Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays
2007
A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non–Small-Cell Lung Cancer
2012
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Determination of 25-OH-PPD in rat plasma by high-performance liquid chromatography–mass spectrometry and its application in rat pharmacokinetic studies
2007
Circadian control of the immune system
2013 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Biodegradation aspects of Polycyclic Aromatic Hydrocarbons (PAHs): A review
2009 Standout
Microfluidic organs-on-chips
2014 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Metal‐Catalyzed Enantioselective Allylation in Asymmetric Synthesis
2007 Standout
In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
2009 StandoutNobel
Heterologous expression of rat P450 2E1 in a mammalian cell line: in situ metabolism and cytotoxicity of N-nitrosodimethylamine
1998
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
2012
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Fondaparinux Sodium Is Not Metabolised in Mammalian Liver Fractions and Does Not Inhibit Cytochrome P450-Mediated Metabolism of Concomitant Drugs
2002
Targeting autophagy in cancer
2017 Standout
Fondaparinux Sodium Mechanism of Action
2002
Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers
2009
Mesoporous Materials for Drug Delivery
2007 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Antimutagens and anticarcinogens: A survey of putative interceptor molecules
1990
Human xylosyltransferases in health and disease
2007
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
In vivo evaluation of matrix granules containing microcrystalline chitosan as a gel-forming excipient
2002
Hypoxia‐Inducible Factor Prolyl‐Hydroxylase: Purification and Assays of PHD2
2007 StandoutNobel
Absorption, Metabolism, and Excretion of Paliperidone, a New Monoaminergic Antagonist, in Humans
2008
Steady-state pharmacokinetics and metabolism of voriconazole in patients
2013
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Appropriate calibration curve fitting in ligand binding assays
2007
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
Quantitative determination of free intracellular α-keto acids in neutrophils
2003
Biological effects of essential oils – A review
2007 Standout
Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine
2008 Standout
Global metabolic profiling procedures for urine using UPLC–MS
2010 Standout
Measurement of Fibrosis Marker Xylosyltransferase I Activity by HPLC Electrospray Ionization Tandem Mass Spectrometry
2006
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples
2003
Separating the wheat from the chaff: a prioritisation pipeline for the analysis of metabolomics datasets
2011
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods
2006
Warfarin Causes Rapid Calcification of the Elastic Lamellae in Rat Arteries and Heart Valves
1998 Standout
One-pot preparation of chiral 2-vinyl-1,4-benzodioxane
1994
Tetrahedron report number 195 (R)- and (S)-2,3-0-isopropylideneglyceraldehyde in stereoselective organic synthesis
1986
Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies
2005
Measurement of Aldosterone in Human Plasma by Semiautomated HPLC–Tandem Mass Spectrometry
2009
From Styrenes to Enantiopure α-Arylglycines in Two Steps
1998 StandoutNobel
Fully Automated Four-Column Capillary LC−MS System for Maximizing Throughput in Proteomic Analyses
2007
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
2004
Bioanalysis without Sample Cleanup or Chromatography: The Evaluation and Initial Implementation of Direct Analysis in Real Time Ionization Mass Spectrometry for the Quantification of Drugs in Biological Matrixes
2008
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 1. General Characteristics
1997 Standout
Test article concentrations in the hERG assay: Losses through the perfusion, solubility and stability
2008
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Studies on Human Pharmaceuticals in Jordanian Wastewater Samples
2014
Ammonia-gas-selective optical sensors based on neutral ionophores
1991
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Evidence for an NIH shift in oxidation of naphthalene by the marine cyanobacterium Oscillatoria sp. strain JCM
1992
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Chirality in α- and β-adrenoceptor agonists and antagonists
1991
Asymmetric dihydroxylation of acrolein acetals: synthesis of stable equivalents of Enantiopure glyceraldehyde and glycidaldehyde
1992 StandoutNobel
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Palladium(0)-Catalyzed Synthesis of 2-Vinyl-2,3-dihydro-benzo[1,4]dioxins
1999
Applications of isotope dilution‐mass spectrometry in clinical chemistry, pharmacokinetics, and toxicology
1992
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients
2004
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 2. Ionophores for Potentiometric and Optical Sensors
1998 Standout
Effects of induction of R- and S-warfarin and metabolite concentrations in rat plasma
1980
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Asymmetric Transition Metal-Catalyzed Allylic Alkylations
1996 Standout
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel

Works of Mark L. Powell being referenced

EVIDENCE FOR AN ARENE OXIDE-NIH SHIFT PATHWAY IN THE METABOLIC CONVERSION OF PROPRANOLOL TO 4’-HYDROXYPROPRANOLOL IN THE RAT AND IN MAN
1979
Comparative steady state bioavailability of conventional and controlled‐release formulations of albuterol
1987
Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control
2003
Direct injection versus liquid-liquid extraction for plasma sample analysis by high performance liquid chromatography with tandem mass spectrometry
1999
Bioanalytical Method Validation—A Revisit with a Decade of Progress
2000 Standout
Increased throughput in quantitative bioanalysis using parallel‐column liquid chromatography with mass spectrometric detection
2001
Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry
2000
An automated method of sample preparation of biofluids using pierceable caps to eliminate the uncapping of the sample tubes during sample transfer
2000
Quantitative analysis of albuterol in human plasma by combined gas chromatography chemical ionization mass spectrometry
1983
Biliary excretion of warfarin metabolites and their metabolism by rat gut flora
1977
Absolute configuration of glycerol derivatives. 6. Cupra A circular dichroism spectra of 3-(aryloxy)-1-(alkylamino)-2-propanol. .beta.-Adrenergic blocking agents
1978
Comparative Bioavailability and Pharmacokinetics of Three Formulations of Albuterol
1985
The effect of N-acetylcysteine on the toxicity induced by N-nitrosodimethylamine.
1988
Absolute configuration of glycerol derivatives. 7. Enantiomers of 2-[[[2-(2,6-dimethoxyphenoxy)ethyl]amino]ethyl]-1,4-benzodioxane (WB-4101), a potent competitive .alpha.-adrenergic antagonist
1979
Relative merits of two methods of sample introduction in inductively coupled plasma mass spectrometry: electrothermal vaporisation and direct sample insertion
1988
Rankless by CCL
2026